I’m Ron Handels, a researcher at the Alzheimer Centrum Limburg at Maastricht University (Netherlands) and affiliated to the Karolinska Institutet (Sweden). I’m working on health-economic topics in Alzheimer’s disease and related disorders.
My current research focuses on estimating the health-economic impact of various (potential) innovations for Alzheimer’s disease. These range from the impact of lifestyle and cardiovascular risk programs for the primary prevention of dementia; impact of advanced diagnostic techniques for the identification of Alzheimer’s disease; the potential cost-effectiveness of future disease-modifying treatment; the health-economic effects of untimely access to professional care for dementia; the cost-effectivenss of a special unit for neuropsychological symptoms in dementia.
I’m part of the international IPECAD working group for the development of an open-source AD health-economic model (supported by the Alzheimer Netherlands fellowship).
Support Alzheimer research at http://www.alzheimeronderzoekfondslimburg.nl/steun-0
Keywords: Health Technology Assessment, health economics, diagnostic evaluation, Alzheimer’s disease, decision making, clinical epidemiology